ImmunityBio, Inc.'s advances with Anktiva & rBCG show promise amid financial hurdles. Click here to find out why IBRX stock ...

The University of Miami Health System, for example, recently opened a medical center in Doral, HCA Florida Healthcare has ...

On March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer pre-chemotherapy. Just six days ...

NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Georgia Urology, recently disclosed that it suffered a data breach that compromised the ...

The following is a summary of “Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with ileal orthotopic neobladder, ureterocutaneostomy or ileal conduit: ...

New research found that people who got surgery on Fridays had a higher risk of adverse outcomes compared to those with Monday ...

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile ...

Partial nephrectomy provides the best survival rates among treatment options in patients aged 75 years or older with T1-T2 renal cell carcinoma (RCC), according to research presented at the 40th ...

Neal Shore, MD, FACS, discussed findings from the SunRISe-4 trial of TAR-200 and cetrelimab in muscle-invasive bladder cancer ...

BALTIMORE, April 1, 2025 (GLOBE NEWSWIRE) — Two’s company, but a lump is a crowd! April is Testicular Cancer Awareness Month, and the Urology Care Foundation (UCF), the official foundation of the ...

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.